Excalibur Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Sell |
|
|||||
|
2025
Q1 | $1.21M | Buy |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $1.22M | Buy |
|
|||||
|
2024
Q2 | $1.24M | Buy |
|
|||||
|
2024
Q1 | $1M | Hold |
|
|||||
|
2023
Q4 | $751K | Hold |
|
|||||
|
2023
Q3 | $692K | Buy |
|
|||||
|
2023
Q2 | $596K | Buy |
|
|||||
|
2023
Q1 | $433K | Hold |
|
|||||
|
2022
Q4 | $462K | Hold |
|
|||||
|
2022
Q3 | $408K | Hold |
|
|||||
|
2022
Q2 | $409K | Buy |
|
|||||
|
2022
Q1 | $361K | Hold |
|
|||||
|
2021
Q4 | $348K | Hold |
|
|||||
|
2021
Q3 | $291K | Hold |
|
|||||
|
2021
Q2 | $289K | Buy |
|
|||||
|
2021
Q1 | $234K | Hold |
|
|||||
|
2020
Q4 | $211K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $205K | Buy |
|